ACCENTIA BIOPHARMACEUTICALS INC (ABPI)

Overview Price 0.25 Price Change Today -$0.01 (-3.85%) P&P rating Zacks Rank N/A - N/A Open Price $0.26 Previous Close $0.26 Daily Range $0.25 - $0.27 52-Week Range $0.25 - $0.59 Volume 111,703 Accentia Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the development of late-stage disruptive clinical products. Accentia has a portfolio of currently marketed respiratory products and a pipeline of products in clinical development. The company's lead respiratory product candidate is SinuNase, which is under clinical development to treat chronic sinusitis. SinuNase is a novel application and formulation of a known anti-fungal exclusively licensed from the Mayo Foundation for Medical Education and Research. The product has been Fast Tracked by the FDA and the Company has commenced a Phase three clinical trial. The Company's other lead product is BiovaxID, a patient-specific anti-cancer vaccine for the treatment of follicular non-Hodgkin's lymphoma. BiovaxID, which is being developed by Accentia's subsidiary Biovest International, Inc. Other Resources for ABPI Detailed Quote Earnings Estimates Company Report Interactive Chart Commentary No Commentary Found for This Ticker. Accentia Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the development of late-stage disruptive clinical products. Accentia has a portfolio of currently marketed respiratory products and a pipeline of products in clinical development. The company's lead respiratory product candidate is SinuNase, which is under clinical development to treat chronic sinusitis. SinuNase is a novel application and formulation of a known anti-fungal exclusively licensed from the Mayo Foundation for Medical Education and Research. The product has been Fast Tracked by the FDA and the Company has commenced a Phase three clinical trial. The Company's other lead product is BiovaxID, a patient-specific anti-cancer vaccine for the treatment of follicular non-Hodgkin's lymphoma. BiovaxID, which is being developed by Accentia's subsidiary Biovest International, Inc.   No brokerage coverage for ABPI   ABPI Ratings: BUY  SELL  HOLD ABPI Consensus Forecasts

Rate this Stock! You haven't rated this stock yet! Ticker Call Buy Sell Analysis Time Frame Week or Less Week to a Month One to Three Months Three to Six Months Six Months to a Year One to Three Years Three Plus Years What The Community Thinks Total Players 7 Buy 0 Sell   Top Buy Analysis No Buy Analysis. Be the First. More Recent Analysis Top Sell Analysis No Sell Analysis. Be the First. More Recent Analysis

Blog Posts

No related Blog Posts.

Commentary

BUY: ACCENTIA BIOPHARMACEUTICALS INC. (ABPI) Start Price: $8.13 Points: -85.50 Created: 01/01/2008 Comments: 0 | Comment Ohscott Recs:

BUY: ACCENTIA BIOPHARMACEUTICALS INC. (ABPI) Start Price: $4.55 Points: -82.16 Created: 01/01/2008 Comments: 0 | Comment Nookster Recs:

BUY: ACCENTIA BIOPHARMACEUTICALS INC. (ABPI) Start Price: $2.84 Points: -77.60 Created: 01/01/2008 Comments: 0 | Comment skibop Recs:

BUY: ACCENTIA BIOPHARMACEUTICALS INC. (ABPI) Start Price: $4.21 Points: -81.55 Created: 01/01/2008 Comments: 0 | Comment RTJ Recs:

BUY: ACCENTIA BIOPHARMACEUTICALS INC. (ABPI) Start Price: $3.00 Points: -78.25 Created: 01/01/2008 Comments: 0 | Comment hawg95 Recs:

BUY: ACCENTIA BIOPHARMACEUTICALS INC. (ABPI) Start Price: $2.59 Points: -76.43 Created: 01/01/2008 Comments: 0 | Comment paulT Recs:

BUY: ACCENTIA BIOPHARMACEUTICALS INC. (ABPI) Start Price: $2.64 Points: -76.68 Created: 01/01/2008 Comments: 0 | Comment greglynx Recs:

Picks

Username	P&P Score	Call	Time Frame	Start Date	Start Price	Today (change)	Stock Gain	S&P Gain	Points	Analysis
Ohscott	58.59	BUY	Six Months to a Year	01/01/2008	$8.13	$0.34 (-11.54%)	-95.76%	-10.25%	-85.50
Nookster	58.59	BUY	Six Months to a Year	01/01/2008	$4.55	$0.34 (-11.54%)	-92.42%	-10.25%	-82.16
skibop		BUY	Six Months to a Year	01/01/2008	$2.84	$0.34 (-11.54%)	-87.85%	-10.25%	-77.60
RTJ	67.44	BUY	Six Months to a Year	01/01/2008	$4.21	$0.34 (-11.54%)	-91.80%	-10.25%	-81.55
hawg95		BUY	Six Months to a Year	01/01/2008	$3.00	$0.34 (-11.54%)	-88.50%	-10.25%	-78.25
paulT	10.72	BUY	Six Months to a Year	01/01/2008	$2.59	$0.34 (-11.54%)	-86.68%	-10.25%	-76.43
greglynx	24.42	BUY	Six Months to a Year	01/01/2008	$2.64	$0.34 (-11.54%)	-86.93%	-10.25%	-76.68